Article Details

Roche provides update on the phase III REMDACTA trial of Actemra/RoActemra plus Veklury in ...

Retrieved on: 2021-03-11 06:00:00

Tags for this article:

Click the tags to see associated articles and topics

Roche provides update on the phase III REMDACTA trial of Actemra/RoActemra plus Veklury in .... View article details on hiswai:

Excerpt

Basel, 11 March 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the global phase III randomised, double-blind, multicentre ...

Article found on: finance.yahoo.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo